Results 231 to 240 of about 190,542 (306)

Soybean Crop Response Treated With Different Multifunctional Inoculants Under Field Conditions

open access: yesEnvironmental Microbiology Reports, Volume 18, Issue 3, June 2026.
Consortia of plant growth‐promoting rhizobacteria (PGPR) enhance soybean phosphorus use efficiency and grain yield under contrasting field conditions. These bioinputs reduce dependence on mineral fertilizers and support eco‐efficient agriculture, offering a sustainable alternative in diverse soil and climate conditions.
Cássia Cristina Rezende Mirza   +7 more
wiley   +1 more source

Ca2+‐Activated Cl− Channels: Do Bestrophins and TMEM16A Interact?

open access: yesActa Physiologica, Volume 242, Issue 6, June 2026.
ABSTRACT Aim Ca2+‐activated Cl– conductances are present in many cell types and are important for regulating membrane potential as well as other cellular functions. TMEM16A is widely accepted as the principal molecular basis for Ca2+‐activated Cl– conductances, but also members of the bestrophin family may be important for some Ca2+‐activated Cl ...
Christian Aalkjær   +4 more
wiley   +1 more source

The Risk of Disease Progression of Type 1 Diabetes in First‐Degree Relatives of People With Type 1 Diabetes: Design and Rationale of a Prospective, Longitudinal Study in China

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 4610-4618, June 2026.
ABSTRACT Aims In China, information on individuals who test positive for islet autoantibodies (IAb), including single IAb‐positive individuals and those with early‐stage Type 1 diabetes (T1D), and their risk of progression to Stage 3 T1D is limited. The goal of this study is to assess the risk of progression to T1D in first‐degree relatives (FDRs) of ...
Lixin Guo   +14 more
wiley   +1 more source

NELF prevents transcriptional readthrough into DNA replication zones in cancer cells. [PDF]

open access: yesEMBO Rep
Nakayama C   +12 more
europepmc   +1 more source

Toward Personalized Medicine in Type 1 Diabetes: Understanding How Patient Heterogeneity Influences Therapeutic Efficacy

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 4529-4545, June 2026.
ABSTRACT Pharmacologic interventions for type 1 diabetes (T1D) have advanced significantly in recent years with the advent of the first FDA approved therapy teplizumab for delaying symptomatic disease onset in 2022. Despite this progress, major hurdles remain in moving toward personalized medicine approaches for T1D.
Jasmine Pipella, Peter J. Thompson
wiley   +1 more source

MdCSN5-MdIAMT module promotes anthocyanin accumulation by regulating IAA homeostasis in apple. [PDF]

open access: yesHortic Res
Zhang J   +12 more
europepmc   +1 more source

Seeing Anxiety: Ecological Video Ethnography and Simulation to Understand Anxiety and Decision‐Making in Dental Care

open access: yesHealth Expectations, Volume 29, Issue 3, June 2026.
ABSTRACT Background Dental anxiety is a widespread barrier to care, often contributing to appointment avoidance, treatment disruption, and emotional strain for both patients and clinicians. While extensively studied as a psychological trait, less attention has been paid to how anxiety manifests situationally and relationally, through non‐verbal ...
Mona Nasser   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy